Operations Director, Liam O’Connell has written an article highlighting the latest data from the IHS Markit Europe PMI Composite Index and it shows a very positive outlook for the pharma and biotech sectors. Take a look at the report here:
The latest IHS Markit Europe PMI Composite Index for July actually showed a slight decline on the previous month for all sectors. Despite this slight cooling from 55.8 in June to 55.3 in July, economic growth across Europe remained strong and among the highest over the last six years.
Beneath the overall figures, the pharmaceutical and biotechnology sectors are gaining momentum with strong order books and profit margins. Alongside transportation, pharma and biotech are the strongest performing sectors at the moment, which is great news for investors and people working in these fields.
The growth of output through July in the pharma and biotech sector is the fastest for the last ten years and considering the sector was in contraction 12 months ago, the growth during this period is extremely positive.
Through 2015/16 the trend in new orders had been negative with companies experiencing a slow down until August 2016 when the rebound started and a change in momentum occurred.
Author: Liam O’Connell